The 20 Best Non-Small Cell Lung Cancer (NSCLC) Doctors Near Me in Texas, US

John Minna is an Oncologist practicing medicine in Dallas, Texas. Dr. Minna is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).

Mara Antonoff is a General Surgeon practicing medicine in Sugar Land, Texas. Dr. Antonoff is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Endoscopy, and Lung Transplant.

David Gerber is an Oncologist practicing medicine in Dallas, Texas. Dr. Gerber is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Endoscopy.

Stephen Swisher is a Thoracic Surgeon practicing medicine in Houston, Texas. Dr. Swisher is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, Endoscopy, and Thymectomy.

Xiuning Le is an Oncologist practicing medicine in Houston, Texas. Dr. Le is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy.

Anne Tsao is an Oncologist practicing medicine in Houston, Texas. Dr. Tsao is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymic Epithelial Tumor, and Tissue Biopsy.

Jonathan Dowell is a Hematologist practicing medicine in Dallas, Texas. Dr. Dowell is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and EGFR Positive Lung Cancer.

Jose Escobar, M.D., spent five years in the Phoenix, Ariz., area pursuing his general surgery residency training, before coming to Texas to further advance his skills. He went on to complete his thoracic surgery residency at the University of Texas Southwestern Medical Center in Dallas. He is a Diplomat of the American Board of Surgery and a Diplomat of the American Board of Thoracic Surgery with special interests that include adult cardiac surgery, minimally invasive thoracic surgery and lung cancer screening program.Prior to founding CVT Surgical Associates of Denton, Escobar served as the medical director of Thoracic Surgery and Cardiovascular Surgery for Baylor Regional Medical Center at Grapevine for six years. He graduated Cum Laude from Texas A&M University in College Station with a bachelor's degree in biology and earned his medical degree from Texas Tech University School of Medicine in Lubbock.Escobar is well-published in the Journal of the American College of Cardiology</em>, Journal of the American Society of Echocardiography</em> and Circulation</em> on such topics as detection of myocardial perfusion defects and the safety and efficacy of fluorocarbon-based echocardiographic contrast agents. He is a member of the American Board of Thoracic Surgery, American Board of Surgery, Cardiothoracic Surgery Network, and Society of Thoracic Surgery.In his free time, Escobar enjoys playing golf and spending time with his family. Dr. Escobar is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Lung Nodules, Fibrosing Mediastinitis, Heart Bypass Surgery, and Aortic Valve Replacement.

Dr. Konduri attended medical school at the University College of Medical Sciences-India. He then completed a residency in Internal Medicine at Rush Presbyterian St Luke's - Westlake Residency Program, Melrose Park, Illinois, followed by a fellowship in Medical Oncology at Baylor University Medical Center, part of Baylor Scott & White Health. Dr. Konduri is certified in Internal Medicine and in Medical Oncology by the American Board of Internal Medicine. He specializes in medical oncology with a particular interest in lung and thoracic oncology. Dr. Konduri is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma. Dr. Konduri is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

Dr. Nadler specializes in medical oncology. He serves as a Medical Director of US Oncology Health Informatics and Internet Technology. He remains active in USON research committees in lung cancer, head and neck cancer, and sarcoma within the developmental committees. Dr. Nadler received a BA with highest honors from Wesleyan University double majoring in molecular biology and philosophy. He received his joint MD/MPP from Harvard Medical School and a Master in Public Policy from Harvard University's Kennedy School of Government. Dr. Nadler then completed his internship and residency in Boston, MA, at Brigham and Women's Hospital in Boston and his oncology fellowship at Dana Farber Cancer Institute/MGH. Dr. Nadler is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Adenoid Cystic Carcinoma, Bone Tumor, and Fibrosarcoma. Dr. Nadler is board certified in Medical Oncology- American Board Of Internal Med/Medical Oncology and Medical Oncology- American Board Of Internal Medicine.

. Dr. Soriano is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Lung Metastases, and Gastrostomy. Dr. Soriano is board certified in American Board Of Internal Medicine.

Vassiliki Papadimitrakopoulou is an Oncologist practicing medicine in Houston, Texas. Dr. Papadimitrakopoulou is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.

After completing his residency and fellowship at Scott & White, Dr. Gowan has spent his entire 20-year professional career in Temple, TX. Initially, he was at Scott & White Memorial which became Baylor Scott & White Health. His primary focus is on thoracic cancers and malignancies of the head and neck. Dr. Gowan's areas of expertise include lung cancer and head and neck cancer. Dr. Gowan is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, Bone Marrow Aspiration, and Endoscopy. Dr. Gowan is board certified in Medical Oncology- American Board Of Internal Medicine.

Garth Beinart is an Oncologist practicing medicine in Houston, Texas. Dr. Beinart is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Paget Disease of the Breast. Dr. Beinart is board certified in American Board Of Internal Medicine – Hematology,, American Board Of Internal Medicine – Oncology, and American Board Of Internal Medicine.

Derrick Nguyen is an Oncologist practicing medicine in Georgetown, Texas. Dr. Nguyen is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Anemia, and Lynch Syndrome.

Prashant Shah is a General Surgeon and a Thoracic Surgeon practicing medicine in Temple, Texas. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Gastrostomy. Dr. Shah is board certified in General Surgery- American Board Of Surgery and Thoracic And Cardiac Surgery- American Board Of Thoracic Surgery.

Dr. Kelly received his medical degree from the Royal College of Surgeons in Ireland in 1998. He completed his internship, residency and oncology fellowship from the Royal College of Physicians in Ireland in 2007. Dr. Kelly completed a second fellowship in medical oncology at the National Cancer Institute (NCI) in Bethesda MD from 2007–2009 and continued as a clinical researcher in thoracic oncology at the NCI until moving to Johns Hopkins in 2011. At Johns Hopkins, Dr. Kelly was the director of the gastroesophageal cancer therapeutics program and also served as the director of global oncology for Johns Hopkins International. Dr. Kelly was recruited as the Director of Oncology for the Charles A. Sammons Cancer Center and the Chief of Oncology for the North Texas Division of the BSWH system in 2018. Dr. Kelly performs translational and clinical research encompassing the discovery and the development of new targeted and immunotherapeutic approaches in the prevention and treatment of gastroesophageal cancer and lung cancer and he is the International principal investigator on a number of global phase II/III clinical trials in these disease areas. In addition he is leading efforts nationally and internationally to design quality metrics for solid tumors and implementing value-based algorithms to help bend the cost curve in the United States. At the Charles A. Sammons Cancer Center he also helps to co-lead the Innovative Clinical Trials Center which investigates novel therapeutics across a range of tumor types. He serves as the co-chair of the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO) taskforce working to improve the quality of care received by lung cancer patients worldwide. He is an active member of ASCO and the Eastern Cooperative Oncology group. He is a founding member of the International Quality Oncology Taskforce in ASCO and serves on the ASCO measures taskforce, the clinical practice committee and the lung cancer quality taskforce. He has authored and co-authored over 150 peer-reviewed publications, abstracts and book chapters, and contributed his work to many prominent healthcare journals. Dr. Kelly’s leadership of oncology services spans Baylor Scott & White’s footprint in the Dallas-Fort Worth area, which includes Baylor University Medical Center—the System’s North Texas flagship hospital and one of the largest cancer hospitals in the nation—as well as a network of 11 Baylor Charles A. Sammons Cancer Centers throughout Texas. Publications. Dr. Kelly is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Esophageal Cancer, Gastroesophageal Junction Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Kelly is board certified in Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Med/Medical Oncology, - American Board Of Internal Med, - American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Medicine, and Medical Oncology- American Board Of Internal Medicine.

James Caccitolo is a Surgical Oncologist and a Thoracic Surgeon practicing medicine in Tyler, Texas. Dr. Caccitolo is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Fibrosing Mediastinitis, Heart Bypass Surgery, and Advanced Bronchoscopy. Dr. Caccitolo is board certified in American Board Of Thoracic Surgery.

Inderpal Sarkaria is a General Surgeon and a Thoracic Surgeon practicing medicine in Dallas, Texas. He has been practicing medicine for over 17 years. Dr. Sarkaria is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Esophageal Cancer, Lung Cancer, Thymectomy, and Endoscopy.

Suman Sinha is a Pulmonary Medicine provider practicing medicine in Tyler, Texas. Dr. Sinha is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Advanced Bronchoscopy, and Gastrostomy. Dr. Sinha is board certified in American Board Of Internal Medicine.